Development and validation of a risk scoring system to predict surgical-site infection after soft-tissue sarcoma resection

JRCT ID: jRCT1040220108

Registered date:23/12/2022

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Soft tissue sarcoma
• Date of first enrollment: 23/12/2022
• Target sample size: 500
• Study type: Observational

Outcome(s)

Primary Outcome

The incidence of surgical site infection and its association with various factors were assessed.
The associations of the clinical parameters, including age, diabetes, smoking during the previous year, tumor location, tumor depth, resected tumor size, operative time, skin graft or flap, preoperative chemotherapy, and radiation therapy, with surgical site infection are investigated

• Secondary Outcome: A scoring system for assessing the risk of SSI in each patient is developed by combining the risk factors.

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients with STS who underwent surgical resection in Kanazawa University Hospital.
• Exclude criteria: Patients with incomplete information regarding the clinical parameter or treatment of the patients.

Related Information

• Primary Sponsor: Miwa Shinji